Analysis-Nestle CEO Freixe's turnaround plan faces challenge from weak consumer October 18, 2024 by True Academy Comments are off
RBC raises KeyCorp stock target on strong growth prospects October 18, 2024 by True Academy Comments are off
Korro Bio shares target lifted, buy rating on RNA editing potential October 18, 2024 by True Academy Comments are off
Badger Meter shares slide over 5% as Q3 results disappoint October 17, 2024 by True Academy Comments are off
Inozyme Pharma presents kidney disease study at ASN Kidney Week October 17, 2024 by True Academy Comments are off
Kezar rejects Concentra's acquisition offer, adopts rights plan October 17, 2024 by True Academy Comments are off
HeartBeam names Robert Eno as new CEO for growth phase October 17, 2024 by True Academy Comments are off
Biognosys showcases plasma proteomics advances at HUPO Congress October 17, 2024 by True Academy Comments are off